Arkolith/Insider Trading/ERNA/Form 4

Binder Brant

DirectorEterna Therapeutics Inc. (ERNA) · full profile →Form 4 · filed Jul 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2023Buy(P)84K$120000.00$10.1B84K
Jul 13, 2023Buy(P)0$0.13$0—

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-034995) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML